Embed Notice

HTML Code

<blockquote style="position: relative; padding-left: 55px;"><section><a href="https://mastodon.uno/users/AlexPed/statuses/113271056679667601">Dr Alex 🩺🚼 (alexped@mastodon.uno)'s status on Tuesday, 08-Oct-2024 18:27:14 JST</a><a href="https://mastodon.uno/@AlexPed" title="alexped@mastodon.uno"><img src="https://gnusocial.jp/avatar/174729-48-20240315092828.webp" width="48" height="48" alt="Dr Alex 🩺🚼" style="position: absolute; left: 0; top: 0;">Dr Alex 🩺🚼</a></section><article><p><a href="https://mastodon.uno/tags/COVID19" rel="tag">#COVID19</a> Therapeutics for Nonhospitalized Older Adults</p><p>📌 Three therapies are recommended among eligible adult outpatients: nirmatrelvir/ritonavir, remdesivir, and molnupiravir</p><p>📌 Because remdesivir requires parenteral administration, the oral antivirals, nirmatrelvir/ritonavir and molnupiravir, are more feasible for widespread use. However, because ritonavir inhibits the cytochrome P450 3A4 (CYP3A)  enzyme, it can interfere with the metabolism of many medications</p><p><a href="https://jamanetwork.com/journals/jama/fullarticle/2824607?guestAccessKey=1e2a25fa-2247-485b-9f10-f3fa630b4c6d&amp;utm_source=silverchair&amp;utm_medium=email&amp;utm_campaign=article_alert-jama&amp;utm_content=olf&amp;utm_term=100724&amp;adv=000001935867" rel="nofollow noreferrer">https://jamanetwork.com/journals/jama/fullarticle/2824607?guestAccessKey=1e2a25fa-2247-485b-9f10-f3fa630b4c6d&amp;utm_source=silverchair&amp;utm_medium=email&amp;utm_campaign=article_alert-jama&amp;utm_content=olf&amp;utm_term=100724&amp;adv=000001935867</a></p></article><footer><a rel="bookmark" href="https://gnusocial.jp/conversation/3792716#notice-7421162">In conversation</a><time datetime="2024-10-08T18:27:14+09:00" title="Tuesday, 08-Oct-2024 18:27:14 JST">about 9 months ago</time> <span>from <span><a href="https://mastodon.uno/@AlexPed/113271056679667601" rel="external" title="Sent from mastodon.uno via ActivityPub">mastodon.uno</a></span></span><a href="https://mastodon.uno/@AlexPed/113271056679667601">permalink</a></footer></blockquote>

Corresponding Notice

Embed this notice
Dr Alex 🩺🚼 (alexped@mastodon.uno)'s status on Tuesday, 08-Oct-2024 18:27:14 JST Dr Alex 🩺🚼
#COVID19 Therapeutics for Nonhospitalized Older Adults
📌 Three therapies are recommended among eligible adult outpatients: nirmatrelvir/ritonavir, remdesivir, and molnupiravir
📌 Because remdesivir requires parenteral administration, the oral antivirals, nirmatrelvir/ritonavir and molnupiravir, are more feasible for widespread use. However, because ritonavir inhibits the cytochrome P450 3A4 (CYP3A) enzyme, it can interfere with the metabolism of many medications
https://jamanetwork.com/journals/jama/fullarticle/2824607?guestAccessKey=1e2a25fa-2247-485b-9f10-f3fa630b4c6d&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jama&utm_content=olf&utm_term=100724&adv=000001935867
In conversationabout 9 months ago from mastodon.unopermalink

Public

Embed Notice

HTML Code

Corresponding Notice